PL1687305T3 - Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych - Google Patents

Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych

Info

Publication number: PL1687305T3
Authority: PL; Poland
Prior art keywords: protein kinase; kinase inhibitors; imidazoquinoline derivatives; imidazoquinoline; imidazoquinolines
Prior art date: 2003-11-21

Application number

PL04798017T

Other languages

English (en)

Inventor

Hans-Georg Capraro

Giorgio Caravatti

Pascal Furet

Carlos Garcia-Echeverria

Patricia Imbach

Frédéric Stauffer

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-21

Filing date

2004-11-19

Publication date

2008-12-31

2004-11-19 Application filed by Novartis Ag filed Critical Novartis Ag

2008-12-31 Publication of PL1687305T3 publication Critical patent/PL1687305T3/pl

Links

RHKWIGHJGOEUSM-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinoline Chemical class C1=CN=C2C(N=CN3)=C3C=CC2=C1 RHKWIGHJGOEUSM-UHFFFAOYSA-N 0.000 title abstract 4
229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
239000003909 protein kinase inhibitor Substances 0.000 title 1
102000001253 Protein Kinase Human genes 0.000 abstract 2
230000001419 dependent effect Effects 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
108060006633 protein kinase Proteins 0.000 abstract 2
SQQXRXKYTKFFSM-UHFFFAOYSA-N chembl1992147 Chemical compound OC1=C(OC)C(OC)=CC=C1C1=C(C)C(C(O)=O)=NC(C=2N=C3C4=NC(C)(C)N=C4C(OC)=C(O)C3=CC=2)=C1N SQQXRXKYTKFFSM-UHFFFAOYSA-N 0.000 abstract 1
229940124669 imidazoquinoline Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL04798017T 2003-11-21 2004-11-19 Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych PL1687305T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US52422903P	2003-11-21	2003-11-21
PCT/EP2004/013178 WO2005054237A1 (en)	2003-11-21	2004-11-19	1h-imidazoquinoline derivatives as protein kinase inhibitors
EP04798017A EP1687305B1 (en)	2003-11-21	2004-11-19	1h-imidazoquinoline derivatives as protein kinase inhibitors

Publications (1)

Publication Number	Publication Date
PL1687305T3 true PL1687305T3 (pl)	2008-12-31

Family

ID=34652264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04798017T PL1687305T3 (pl)	2003-11-21	2004-11-19	Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych

Country Status (16)

Country	Link
US (1)	US20080262021A1 (pl)
EP (1)	EP1687305B1 (pl)
JP (1)	JP2007511575A (pl)
KR (1)	KR20060117329A (pl)
CN (1)	CN1902200A (pl)
AT (1)	ATE400573T1 (pl)
AU (1)	AU2004295061B2 (pl)
BR (1)	BRPI0416801A (pl)
CA (1)	CA2546117A1 (pl)
DE (1)	DE602004014969D1 (pl)
ES (1)	ES2308272T3 (pl)
MX (1)	MXPA06005702A (pl)
PL (1)	PL1687305T3 (pl)
PT (1)	PT1687305E (pl)
RU (1)	RU2006121646A (pl)
WO (1)	WO2005054237A1 (pl)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005538057A (ja)	2002-06-07	2005-12-15	スリーエムイノベイティブプロパティズカンパニー	エーテル置換イミダゾピリジン
EP1590348A1 (en)	2002-12-20	2005-11-02	3M Innovative Properties Company	Aryl / hetaryl substituted imidazoquinolines
US20040265351A1 (en)	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
NZ545412A (en)	2003-08-27	2008-12-24	Coley Pharm Group Inc	Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja)	2003-09-05	2007-03-01	スリーエムイノベイティブプロパティズカンパニー	Ｃｄ５＋ｂ細胞リンパ腫の治療方法
EP1673087B1 (en)	2003-10-03	2015-05-13	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
KR101494056B1 (ko)	2003-10-03	2015-02-16	쓰리엠 이노베이티브 프로퍼티즈 컴파니	피라졸로피리딘 및 그의 유사체
AU2004293078B2 (en)	2003-11-25	2012-01-19	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
JP5209312B2 (ja)	2004-09-02	2013-06-12	スリーエムイノベイティブプロパティズカンパニー	１−アルコキシ１ｈ−イミダゾ環系および方法
JP5313502B2 (ja)	2004-12-30	2013-10-09	スリーエムイノベイティブプロパティズカンパニー	置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2592904C (en)	2004-12-30	2015-04-07	3M Innovative Properties Company	Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP2008530022A (ja)	2005-02-04	2008-08-07	コーリーファーマシューティカルグループ，インコーポレイテッド	免疫反応調節物質を含む水性ゲル処方物
US20080318998A1 (en)	2005-02-09	2008-12-25	Coley Pharmaceutical Group, Inc.	Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
CA2602083A1 (en)	2005-02-09	2006-08-09	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
EP1846405A2 (en)	2005-02-11	2007-10-24	3M Innovative Properties Company	Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2597446A1 (en)	2005-02-11	2006-08-31	Coley Pharmaceutical Group, Inc.	Substituted imidazoquinolines and imidazonaphthyridines
EP1851218A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazoquinoline compounds and methods
AU2006216686A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Method of preferentially inducing the biosynthesis of interferon
AU2006223634A1 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
CA2598639A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazonaphthyridines
CA2602590A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2602683A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	Pyrazolopyridine-1,4-diamines and analogs thereof
GB0510390D0 (en) *	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
AU2006287270A1 (en)	2005-09-09	2007-03-15	Coley Pharmaceutical Group, Inc.	Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
WO2007056112A2 (en)	2005-11-04	2007-05-18	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
EP1988896A4 (en)	2006-02-22	2011-07-27	3M Innovative Properties Co	CONJUGATES TO MODIFY IMMUNE REACTIONS
WO2007106854A2 (en)	2006-03-15	2007-09-20	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
US8168383B2 (en)	2006-04-14	2012-05-01	Cell Signaling Technology, Inc.	Gene defects and mutant ALK kinase in human solid tumors
EP2447359B1 (en)	2006-04-14	2015-11-04	Cell Signaling Technology, Inc.	Gene defects and mutant ALK kinase in human solid tumors
WO2008008432A2 (en)	2006-07-12	2008-01-17	Coley Pharmaceutical Group, Inc.	Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US8178539B2 (en)	2006-09-06	2012-05-15	3M Innovative Properties Company	Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
KR20090080530A (ko)	2006-11-20	2009-07-24	노파르티스 아게	2-메틸-2-[4-(3-메틸-2-옥소-8-퀴놀린-3-일-2,3-디히드로-이미다조[4,5-ｃ]퀴놀린-1-일)-페닐]-프로피오니트릴의 염 및 결정 형태
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
RU2478387C2 (ru) *	2007-02-20	2013-04-10	Новартис Аг	ИМИДАЗОХИНОЛИНЫ В КАЧЕСТВЕ ДВОЙНЫХ ИНГИБИТОРОВ ЛИПИДКИНАЗЫ И mTOR
MX2010007699A (es) *	2008-01-15	2010-08-04	Meda Ab	Tratamiento de enfermedades del colon o prevencion de carcinoma colorrectal con derivados de imidazoquinolina.
EP2474323A3 (en) *	2008-03-26	2012-10-10	Novartis AG	Imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
BRPI1008325A2 (pt)	2009-02-11	2020-08-25	Merck Patent Gmbh	carboxamidas azaeterocíclicas de amino
GEP20156267B (en)	2009-06-04	2015-04-14	Novartis Ag	1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
ES2668775T3 (es) *	2009-06-10	2018-05-22	Chugai Seiyaku Kabushiki Kaisha	Compuestos tetracíclicos
BR112012002336A2 (pt)	2009-08-07	2016-05-31	Merck Patent Gmbh	compostos aza-heterocíclicos
JP5863058B2 (ja)	2010-05-17	2016-02-16	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	１Ｈ−イミダゾ［４，５−ｃ］キノリン
KR102015402B1 (ko)	2010-05-20	2019-08-28	어레이 바이오파마 인크.	Trk 키나제 저해제로서의 매크로시클릭 화합물
TW201204725A (en) *	2010-07-16	2012-02-01	Piramal Lifesciences Ltd	Substituted imidazoquinoline derivatives as kinase inhibitors
UA110113C2 (xx)	2010-07-29	2015-11-25		Біциклічні азагетероциклічні карбоксаміди
BR112013002212A2 (pt)	2010-07-29	2017-09-26	Merck Patent Gmbh	carboxamidas aza-heterocíclicas de aminas cíclicas
US20120101108A1 (en)	2010-08-06	2012-04-26	Cell Signaling Technology, Inc.	Anaplastic Lymphoma Kinase In Kidney Cancer
LT2606047T (lt)	2010-08-17	2017-04-10	3M Innovative Properties Company	Imuninio atsako modifikatoriaus junginio lipidizuotos kompozicijos, sudėtys ir būdai
MX355836B (es)	2010-08-20	2018-05-02	Chugai Pharmaceutical Co Ltd	Composicion que comprende compuestos tetraciclicos.
US9181264B2 (en)	2010-09-16	2015-11-10	Hutchison Medipharma Limited	Fused heteroaryls and their uses
CN103124731B (zh) *	2010-09-16	2016-01-20	和记黄埔医药（上海）有限公司	稠合的杂芳基化合物及其应用
US20130225524A1 (en) *	2010-11-05	2013-08-29	Deping Chai	Chemical Compounds
WO2012069146A1 (en)	2010-11-24	2012-05-31	Merck Patent Gmbh	Quinazoline carboxamide azetidines
KR20140010009A (ko) *	2010-12-03	2014-01-23	노파르티스 아게	제약 조성물
JO3003B1 (ar)	2011-01-14	2016-09-05	Lilly Co Eli	مركب أيميدازو [4، 5 -c ] كينولين-2- واحد واستخدامه كمثبط كيناز PI3/mtor
CA2838023C (en)	2011-06-03	2019-08-13	3M Innovative Properties Company	Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
EP2717919B1 (en)	2011-06-03	2016-08-03	3M Innovative Properties Company	Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
GB201114103D0 (en)	2011-08-17	2011-09-28	Glaxosmithkline Llc	Novel compounds
SI2755965T1 (sl)	2011-09-12	2017-12-29	Merck Patent Gmbh	Novi imidazolni amidi kot modulatorji kinazne aktivnosti
SG2014009260A (en)	2011-09-12	2014-09-26	Merck Patent Gmbh	Aminopyrimidine derivatives for use as modulators of kinase activity
CN103012398B (zh) *	2011-09-19	2015-10-14	上海恒瑞医药有限公司	咪唑并喹啉类衍生物及其可药用盐、其制备方法及其在医药上的应用
ES2527188T3 (es) *	2011-09-26	2015-01-21	Sanofi	Derivados de pirazolquinolinona, su preparación y su uso terapéutico
JP6096205B2 (ja)	2011-11-01	2017-03-15	モッドジーンリミテッドライアビリティカンパニーＭｏｄｇｅｎｅ，Ｌｌｃ	低減されたタンパク質キナーゼ阻害を呈するイマチニブ誘導体の使用
BR112014015327B1 (pt)	2011-12-22	2020-10-27	Merck Patent Gmbh	composto, seu uso e composição farmacêutica
US10668075B2 (en)	2012-09-25	2020-06-02	Chugai Seiyaku Kabushiki Kaisha	RET inhibitor
JP6386467B2 (ja)	2012-11-16	2018-09-05	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	キナーゼ活性のモジュレーターとしての新規複素環式誘導体
ES2807539T3 (es)	2012-11-16	2021-02-23	Merck Patent Gmbh	Derivados de imidazol-piperidinilo como moduladores de la actividad de quinasa
WO2014085528A1 (en)	2012-11-29	2014-06-05	Merck Patent Gmbh	Azaquinazoline carboxamide derivatives
WO2014121654A1 (zh) *	2013-02-05	2014-08-14	山东轩竹医药科技有限公司	四并环激酶抑制剂
SG11201505999VA (en)	2013-03-11	2015-08-28	Merck Patent Gmbh	6-[4-(1 h-imidazol-2-yl)piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity
WO2014177915A1 (en) *	2013-05-01	2014-11-06	Piramal Enterprises Limited	Cancer combination therapy using imidazo[4,5-c]quinoline derivatives
WO2015022663A1 (en) *	2013-08-14	2015-02-19	Novartis Ag	Compounds and compositions as inhibitors of mek
WO2015022664A1 (en) *	2013-08-14	2015-02-19	Novartis Ag	Compounds and compositions as inhibitors of mek
US9227969B2 (en)	2013-08-14	2016-01-05	Novartis Ag	Compounds and compositions as inhibitors of MEK
AU2015240094B2 (en)	2014-04-03	2020-07-30	Merck Patent Gmbh	Combinations of cancer therapeutics
WO2015163448A1 (ja)	2014-04-25	2015-10-29	中外製薬株式会社	４環性化合物を高用量含有する製剤
EP3135671B1 (en)	2014-04-25	2019-09-18	Chugai Seiyaku Kabushiki Kaisha	Novel crystal of tetracyclic compound
NO2714752T3 (pl)	2014-05-08	2018-04-21
TWI831347B (zh)	2014-08-08	2024-02-01	日商中外製藥股份有限公司	包含４環性化合物的非晶質體之固體分散體及製劑
JP6741596B2 (ja)	2015-01-16	2020-08-19	中外製薬株式会社	併用医薬
HUE053067T2 (hu)	2015-07-16	2021-06-28	Array Biopharma Inc	Helyettesített pirazolo[1,5-A]piridin vegyületek, mint RET kináz inhibitorok
GB201516504D0 (en)	2015-09-17	2015-11-04	Astrazeneca Ab	Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer
TWI704148B (zh)	2016-10-10	2020-09-11	美商亞雷生物製藥股份有限公司	作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
TWI752098B (zh)	2016-10-10	2022-01-11	美商亞雷生物製藥股份有限公司	作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
US10988472B2 (en)	2016-10-13	2021-04-27	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Compounds and method for blocking transmission of malarial parasite
WO2018136663A1 (en)	2017-01-18	2018-07-26	Array Biopharma, Inc.	Ret inhibitors
US11168090B2 (en)	2017-01-18	2021-11-09	Array Biopharma Inc.	Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
JOP20190213A1 (ar)	2017-03-16	2019-09-16	Array Biopharma Inc	مركبات حلقية ضخمة كمثبطات لكيناز ros1
WO2019040491A1 (en)	2017-08-22	2019-02-28	Dynavax Technologies Corporation	MODIFIED ALKYL CHAIN IMIDAZOQUINOLINE TLR7 / 8 AGONIST COMPOUNDS AND USES THEREOF
TWI812649B (zh)	2017-10-10	2023-08-21	美商絡速藥業公司	6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
TWI791053B (zh)	2017-10-10	2023-02-01	美商亞雷生物製藥股份有限公司	6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
US10722591B2 (en)	2017-11-14	2020-07-28	Dynavax Technologies Corporation	Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof
EP3728255B1 (en)	2017-12-20	2022-01-26	3M Innovative Properties Company	Amide substituted imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
EP3740490A1 (en)	2018-01-18	2020-11-25	Array Biopharma, Inc.	Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors
CA3087972C (en)	2018-01-18	2023-01-10	Array Biopharma Inc.	Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors
EP3740491A1 (en)	2018-01-18	2020-11-25	Array Biopharma, Inc.	Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
CN112384223B (zh)	2018-06-29	2024-08-27	中外制药株式会社	含有难溶性碱性药剂的药物组合物
WO2020050241A1 (ja)	2018-09-04	2020-03-12	中外製薬株式会社	４環性化合物の製造方法
JP2022500383A (ja)	2018-09-10	2022-01-04	アレイバイオファーマインコーポレイテッド	Ｒｅｔキナーゼ阻害剤としての縮合複素環式化合物
CN118619944A (zh)	2019-06-06	2024-09-10	北京泰德制药股份有限公司	作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物
JP2023551408A (ja)	2020-11-16	2023-12-08	メルクパテントゲゼルシャフトミットベシュレンクテルハフツング	がん処置のためのキナーゼインヒビター組み合わせ
CN117800964A (zh) *	2022-09-30	2024-04-02	四川大学	PI3K/m-TOR抑制剂及其应用
CN121219289A (zh) *	2024-04-26	2025-12-26	浙江师范大学	吡啶或吡嗪并三环化合物及其药用组合物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4323388A (en) *	1980-03-10	1982-04-06	Ciba-Geigy Corporation	Cyanoalkyl-phenylureas having selective herbicidal activity
US4929624A (en) *	1989-03-23	1990-05-29	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5389640A (en) *	1991-03-01	1995-02-14	Minnesota Mining And Manufacturing Company	1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
JP2000119271A (ja) *	1998-08-12	2000-04-25	Hokuriku Seiyaku Co Ltd	１ｈ―イミダゾピリジン誘導体
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
EP1256582A1 (en) *	2000-02-09	2002-11-13	Hokuriku Seiyaku Co., Ltd.	1h-imidazopyridine derivatives
UA74852C2 (en) *	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
EP1590348A1 (en) *	2002-12-20	2005-11-02	3M Innovative Properties Company	Aryl / hetaryl substituted imidazoquinolines

2004
- 2004-11-19 JP JP2006540347A patent/JP2007511575A/ja active Pending
- 2004-11-19 PT PT04798017T patent/PT1687305E/pt unknown
- 2004-11-19 CN CNA2004800391141A patent/CN1902200A/zh active Pending
- 2004-11-19 AU AU2004295061A patent/AU2004295061B2/en not_active Ceased
- 2004-11-19 EP EP04798017A patent/EP1687305B1/en not_active Expired - Lifetime
- 2004-11-19 DE DE602004014969T patent/DE602004014969D1/de not_active Expired - Lifetime
- 2004-11-19 WO PCT/EP2004/013178 patent/WO2005054237A1/en not_active Ceased
- 2004-11-19 MX MXPA06005702A patent/MXPA06005702A/es active IP Right Grant
- 2004-11-19 CA CA002546117A patent/CA2546117A1/en not_active Abandoned
- 2004-11-19 RU RU2006121646/04A patent/RU2006121646A/ru not_active Application Discontinuation
- 2004-11-19 PL PL04798017T patent/PL1687305T3/pl unknown
- 2004-11-19 ES ES04798017T patent/ES2308272T3/es not_active Expired - Lifetime
- 2004-11-19 AT AT04798017T patent/ATE400573T1/de not_active IP Right Cessation
- 2004-11-19 US US10/579,587 patent/US20080262021A1/en not_active Abandoned
- 2004-11-19 KR KR1020067009923A patent/KR20060117329A/ko not_active Withdrawn
- 2004-11-19 BR BRPI0416801-1A patent/BRPI0416801A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2006121646A (ru)	2008-01-10
WO2005054237A1 (en)	2005-06-16
CA2546117A1 (en)	2005-06-16
EP1687305B1 (en)	2008-07-09
CN1902200A (zh)	2007-01-24
MXPA06005702A (es)	2006-08-17
EP1687305A1 (en)	2006-08-09
ATE400573T1 (de)	2008-07-15
BRPI0416801A (pt)	2007-01-09
ES2308272T3 (es)	2008-12-01
PT1687305E (pt)	2008-10-17
AU2004295061A1 (en)	2005-06-16
AU2004295061B2 (en)	2008-11-20
KR20060117329A (ko)	2006-11-16
DE602004014969D1 (de)	2008-08-21
JP2007511575A (ja)	2007-05-10
US20080262021A1 (en)	2008-10-23

Publication	Publication Date	Title
PT1687305E (pt)	2008-10-17	Derivados de 1h-imidazoquinolina como inibidores de proteína quinase
MY142019A (en)	2010-08-16	Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
GB0211649D0 (en)	2002-07-03	Organic compounds
MXPA06000302A (es)	2006-04-18	Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
TW200833693A (en)	2008-08-16	Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MY143206A (en)	2011-03-31	1h-thieno 2,3-c pyrazole derivatives useful as kinase i inhibitors
PL2324008T3 (pl)	2012-09-28	3,4-diarylopirazole jako inhibitory kinazy białkowej
ATE411022T1 (de)	2008-10-15	Pyridylpyrrol-derivate als wirksame kinase-hemmer
WO2009071480A3 (en)	2009-11-05	Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
MX2009006401A (es)	2009-06-23	Derivados de indazol como inhibidores de cinasa para el tratamiento del cancer.
MY139072A (en)	2009-08-28	Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
ATE396986T1 (de)	2008-06-15	Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
GB0112348D0 (en)	2001-07-11	Compounds
WO2006059234A3 (en)	2006-07-20	Bicyclic amides as kinase inhibitors
WO2005097135A3 (en)	2006-02-16	Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives
UA102219C2 (ru)	2013-06-25	Замещенные пиразолохиназолиновые производные, способ их получения и их применения как ингибиторов киназы
NO20063768L (no)	2006-11-02	1H-tieno[2,3c] pyrazolderivater anvendelige som kinaseinhibitorer
WO2004016741A3 (en)	2004-04-08	Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
TW200502236A (en)	2005-01-16	Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
ATE402178T1 (de)	2008-08-15	Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten